help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2009-0162
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Stuart, C. A.
Right arrow Articles by Yin, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stuart, C. A.
Right arrow Articles by Yin, D.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 9 3535-3542
Copyright © 2009 by The Endocrine Society

Insulin-Stimulated Translocation of Glucose Transporter (GLUT) 12 Parallels That of GLUT4 in Normal Muscle

Charles A. Stuart, Mary E. A. Howell, Yi Zhang and Deling Yin

The Department of Internal Medicine, East Tennessee State University, Quillen College of Medicine, Johnson City, Tennessee 37614-0622

Address all correspondence and requests for reprints to: Charles A. Stuart, M.D., East Tennessee State University, Quillen College of Medicine, P.O. Box 70622, Johnson City, Tennessee 37614-0622. E-mail: stuartc{at}etsu.edu.

Context: GLUT4 is the predominant glucose transporter isoform expressed in fat and muscle. In GLUT4 null mice, insulin-stimulated glucose uptake into muscle was diminished but not eliminated, suggesting that another insulin-sensitive system was present.

Objective: This study was intended to determine whether insulin caused GLUT12 translocation in muscle.

Design: Six normal volunteers had muscle biopsies before and after euglycemic insulin infusions.

Setting: Infusions and biopsies were performed in an outpatient clinic.

Participants: Subjects were nonobese, young adults with no family history of diabetes.

Main Outcome Measures: GLUT12, GLUT4, and GLUT1 proteins were quantified in muscle biopsy fractions. Cultured myoblasts were used to determine whether GLUT12 translocation was phosphatidyl inositol-3 kinase (PI3-K)-dependent.

Intervention. Insulin was infused at 40 mU/m2 · min for 3 h.

Results: In human muscle, insulin caused a shift of a portion of GLUT12 from intracellular low-density microsomes to the plasma membrane (PM) fraction (17% in PM at baseline, 38% in PM after insulin). Insulin increased GLUT4 in PM from 13 to 42%. GLUT1 was predominantly in the PM fractions at baseline and did not change significantly after insulin. L6 myoblasts in culture also expressed and translocated GLUT12 in response to insulin, but inhibiting PI3-K prevented the translocation of GLUT12 and GLUT4.

Conclusions: Insulin causes GLUT12 to translocate from an intracellular location to the plasma membrane in normal human skeletal muscle. Translocation of GLUT12 in cultured myoblasts was dependent on activation of PI3-K. GLUT12 may have evolutionarily preceded GLUT4 and now provides redundancy to the dominant GLUT4 system in muscle.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society